Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT
Seres Therapeutics Fail-to-Deliver
Total FTD Shares
1.17K
Below Average
FTD / Avg. Volume
0.99%
Low Impact
1-Year Change
-96.5%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Seres Therapeutics Inc. has
1,170
shares failed to deliver, representing 0.99%
of the average daily volume of
118,508
shares. Over the past year, the monthly average FTD is
56,394
shares, with the current level 98% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 14.85 | 1.17K | -65.37% |
Jun 30, 2025 | 11.11 | 3.38K | +227.74% |
May 30, 2025 | 7.05 | 1.03K | +103000.00% |
Apr 30, 2025 | 9.7 | 1 | -100.00% |
Mar 31, 2025 | 14 | 26.5K | +2824.83% |
Feb 28, 2025 | 15.19 | 906 | +806.00% |
Jan 30, 2025 | 17.13 | 100 | -95.83% |
Dec 30, 2024 | 16.61 | 2.4K | -81.96% |
Nov 29, 2024 | 19.6 | 13.3K | -85.25% |
Oct 31, 2024 | 16.4 | 90.2K | +1960.21% |
Sep 30, 2024 | 18.92 | 4.38K | +178.68% |
Aug 30, 2024 | 16.01 | 1.57K | -84.97% |
Jul 31, 2024 | 26.8 | 10.45K | -73.69% |
Jun 28, 2024 | 14.48 | 39.72K | +75.19% |
May 31, 2024 | 20 | 22.67K | -72.26% |
Apr 29, 2024 | 18.18 | 81.72K | +9.85% |
Mar 28, 2024 | 15.48 | 74.39K | +30141.06% |
Feb 29, 2024 | 22.8 | 246 | -95.18% |
Jan 31, 2024 | 22.6 | 5.1K | -77.89% |
Dec 28, 2023 | 28 | 23.07K | -60.74% |
Nov 30, 2023 | 20.8 | 58.77K | -48.77% |
Oct 31, 2023 | 30.6 | 114.71K | +973.22% |
Sep 29, 2023 | 47.6 | 10.69K | -87.05% |
Aug 14, 2023 | 76.8 | 82.5K | +1722.06% |
Jul 31, 2023 | 96.2 | 4.53K | -88.34% |
Jun 30, 2023 | 95.8 | 38.84K | +793.38% |
May 25, 2023 | 93.4 | 4.35K | -33.70% |
Apr 28, 2023 | 97.6 | 6.56K | -38.27% |
Mar 28, 2023 | 111 | 10.62K | +88433.33% |
Feb 21, 2023 | 100.2 | 12 | -99.34% |
Jan 31, 2023 | 109.4 | 1.82K | n/a |